The law firm said it is examining whether Amneal and its officers or directors may have violated securities laws or breached fiduciary duties, and invited current shareholders to seek more information.
Kaskela Law said it is investigating Amneal Pharmaceuticals, Inc. on behalf of the company’s current shareholders over recent corporate actions. The inquiry is focused on whether Amneal and/or the company’s officers and directors violated securities laws or breached fiduciary duties, according to the announcement. The firm asked Amneal shareholders to contact Kaskela Law LLC for more information about the investigation and their legal rights and options. The release also said the plaintiff-side firm, which handles securities fraud, corporate governance, and merger and acquisition litigation on a contingent basis, has helped recover over $500 million for investors since 2020.